Washington DC
New York
Toronto
Distribution: (800) 510 0384
Press ID
  • Login
Fairmont Post
No Result
View All Result
Sunday, November 15, 2026
  • Business • Financial
  • Culture • Entertainment
  • Lifestyle • Travel
  • Technology • Science
  • Environment • Conservation
  • FinTech • Blockchain
  • Business • Financial
  • Culture • Entertainment
  • Lifestyle • Travel
  • Technology • Science
  • Environment • Conservation
  • FinTech • Blockchain
No Result
View All Result
Fairmont Post
No Result
View All Result

Tonix Pharmaceuticals Developing Vaccine Candidate to Combat Mpox Crisis and Potential Future Pandemics

Marc Brousseau by Marc Brousseau
August 23, 2024
in Science
A A

Following an upsurge of cases in the Democratic Republic of the Congo and several other countries in Africa, the World Health Organization (WHO) declared mpox a public health emergency of international concern on Aug. 14 – the second such declaration in two years. The WHO has called on vaccine manufacturers to step up efforts to curb the spread of a new, more deadly strain of the virus.

The WHO also is asking companies and organizations to bring in their vaccines, inviting developers of mpox vaccines to submit an Expression of Interest for Emergency Use Listing (EUL).

READ ALSO

JSTOR Academic Journals: A Research Resource Guide

Vilnius University Researchers Validate Tool to Spot Burnout Risk Before It Turns Serious

Amid this backdrop, Tonix Pharmaceuticals (NASDAQ:TNXP) is developing a vaccine candidate, called TNX-801, that could play a role in combating this escalating global health crisis. Tonix has successfully completed non-human primate studies showing protection from challenge with lethal doses of the Clade 1 monkeypox virus that is driving the new epidemic.

Clearly more testing is ahead for TNX-801, but the technology behind it is rooted in the science of Edward Jenner’s smallpox vaccine of the late 1700s, the only vaccine to successfully eradicate a contagious viral pathogen.

These credentials have earned the vaccine technology platform upon which TNX-801 is based a competitive spot in the NIH’s NextGen program for a more effective, single-dose COVID-19 vaccine to potentially provide durable protection instead of the every-six month booster strategy of mRNA vaccines.

Last month, another of Tonix’s technologies was awarded a contract for up to $34 million by the U.S. Department of Defense to develop a single broad spectrum antiviral that would work against multiple potential biowarfare agents.

An Historical Approach to Modern Challenges

The current mpox crisis can be traced back to a decision made in the 1970s to discontinue routine smallpox vaccinations after smallpox was successfully eradicated. Research shows that the smallpox vaccine also provided immunity against mpox. In retrospect, smallpox vaccination kept mpox out of the human population in Africa. So an unintended consequence of stopping vaccinations for smallpox meant that mpox, then known as monkeypox (which is still the name of the virus), was able to reemerge in the human population.

Tonix’s mpox vaccine is believed to be closely related to the original smallpox vaccine invented by British physician Edward Jenner in 1796. Jenner’s vaccine is credited with being the first and only vaccine to successfully eradicate a viral pathogen. This triumph depended on several important attributes of the vaccine, including that it was generally well-tolerated, provided long-term immunity with a single dose, prevented forward transmission and provided a simple biomarker confirmation of protective immunity known as a “take”.

TNX-801 is designed to have these same attributes; it is delivered in a single dose that provides protective immunity to animals that is marked by a “take”. It is believed to have a high likelihood of providing durable immunity and preventing forward transmission. Furthermore, unlike many other vaccines, TNX-801 does not require complex ultra cold-chain storage, making it a strong candidate for global distribution.

The Science Behind TNX-801

Unlike mRNA vaccines, which primarily elicit an antibody response that requires frequent booster shots, TNX-801 is designed to trigger a robust T-cell response. T-cells have the ability to recognize and remember internal parts of viral proteins, not just those on the surface. T-cell memory lasts for years – even decades – providing long-term immunity and potentially eliminating the need for repeated boosters.

In preclinical trials, Tonix says TNX-801 demonstrated the ability to prevent death, clinical disease and lesions caused by a lethal challenge of monkeypox virus in non-human primates. Similar to Jenner’s smallpox vaccine, TNX-801 also significantly reduced viral shedding, suggesting that it can block forward transmission,. Tonix is rushing to manufacture vaccine suitable for Phase 1 human trials.

Beyond Mpox: A Platform for Future Pandemics

The vaccine platform on which TNX-801 is based has potential applications beyond mpox. The company says the TNX-1800 version of the platform, for example, is designed to protect against COVID-19 and has shown promise in preclinical studies. The U.S. National Institute of Health has recognized the potential of Tonix’s platform by selecting it for Project NextGen, aimed at developing next-generation COVID-19 vaccines and pandemic platform technologies.

As the world faces the growing threat of mpox and other infectious diseases, Tonix Pharmaceuticals is not only attempting to address the current crisis with TNX-801, but also potentially contributing to a future where pandemics can be more predictably contained.

FP Newsroom

Science

JSTOR Academic Journals: A Research Resource Guide

August 31, 2026
Vilnius University Researchers Validate Tool to Spot Burnout Risk Before It Turns Serious
Science

Vilnius University Researchers Validate Tool to Spot Burnout Risk Before It Turns Serious

July 22, 2026
Dr. Jay Bhaumik Explores How Pharmacies Can Improve Adherence Through Smart Technology
Science

Dr. Jay Bhaumik Explores How Pharmacies Can Improve Adherence Through Smart Technology

February 20, 2026
The Future of Pharmacy: How AI Is Changing the Way You Get Your Medications, According to Expert Jay Bhaumik
Science

The Future of Pharmacy: How AI Is Changing the Way You Get Your Medications, According to Expert Jay Bhaumik

August 8, 2025
Senegal Becomes 56th Signatory of Artemis Accords at NASA HQ
Science

Senegal Becomes 56th Signatory of Artemis Accords at NASA HQ

July 25, 2025
New Longevity Fund Unleashes $40 Million to Transform Life Extension Technologies and Redefine Aging
Science

New Longevity Fund Unleashes $40 Million to Transform Life Extension Technologies and Redefine Aging

July 16, 2025

News in Focus

  • College Costs Consume Up to 90 Percent of Median Household Income in Some States, WalletHub Finds
  • From Public Service to City Hall: How Experience Shapes My Approach to Governing
  • UNCTAD: Accelerating Climate Action Requires Trade Cooperation
  • Democratic Midterm Gains Shift Energy Oversight, Data-Center Rules, and Renewable Prospects
  • Housing Affordability Looms Over Midterm Ballots as Mortgage Rates Hold Above 7%
  • Pruvon Is Built Around the Charges It Cannot Categorise on Its Own
  • ADC Launches Portal to Document CBP Electronic Device Seizures at U.S. Borders
  • Beacon Hill Residents Take High-Speed Hellcat Rides at Autobahn Country Club
  • Nebraska Tops WalletHub’s 2026 Ranking of Best States for Jobs
  • Chatham Park Builders Take Gold and Bronze in 2026 Triangle Parade of Homes
  • Choosing a Fleet Tracking System: Questions to Ask Before You Commit
  • Why Most Factory AI Projects Stall, According to Automated Industrial Robotics (AIR) Leader Darragh de Stonndún
  • Alec Lawler on Turning Market Challenges Into Strategic Opportunities
  • Paramount Closes Warner Bros. Discovery Deal, Trades as Skydance
  • Antoine Souma Discusses Who Collects the Premium
  • Quantron Framework Targets 2,000 Zero-Emission Trucks for Shaoxing by 2030
  • Zelle Infrastructure Architect Arthur Miller Publishes AI-SDLC Framework as Enterprises Confront 98% Faster Software Delivery
  • High Seas Treaty Hits 100 Parties After Six New Ratifications
  • Gastauer Family Office Connects Capital With Impact Information
  • Bipartisan Bill Seeks Health Standards for Federal Wildland Firefighters
  • Fort Hunter Liggett Keeps Training on as Plaskett Fire Nears 90% Containment
  • E Magazines: The Complete Guide for Publishers in 2026
  • Volatile Markets: Navigating Uncertainty in 2026
  • Media Finance: The Complete Guide for 2026
  • Entrepreneurship News: Key Trends Shaping 2026
  • How Real-Time 3D Is Changing the Way We Buy Homes

https://ritzherald.com/how-real-time-3d-is-changing-the-way-we-buy-homes/

#RealEstate #HomeBuying #3D #RealTime3D #PropTech #DigitalTwin #VirtualTour #HomeBuyers #RealEstateTech #PropertyMarketing #3DVisualization #InteractiveHome #FutureOfRealEstate #TechInRealEstate #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • The Biggest Compliance Challenges Small Businesses Face in 2026

https://hudsonweekly.com/the-biggest-compliance-challenges-small-businesses-face-in-2026/

#SmallBusiness #Compliance #BusinessCompliance #DataPrivacy #Cybersecurity #GDPR #CCPA #SmallBusinessTips #RegulatoryCompliance #BusinessRisk #FinancialCompliance #2026Business #SMB #ComplianceChallenges #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • Delayed Cancer Diagnosis: Where Screening and Follow-Up Break Down

https://ritzherald.com/delayed-cancer-diagnosis-where-screening-and-follow-up-break-down/

#CancerDiagnosis #DelayedDiagnosis #CancerScreening #MedicalMalpractice #EarlyDetection #CancerAwareness #PatientSafety #Healthcare #MedicalError #CancerCare #Misdiagnosis #HealthRights #CancerPrevention #PatientAdvocacy #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • The Winter Home Décor Trends Bringing Warmth & Personality Into Modern Homes This Season

https://ritzherald.com/the-winter-home-decor-trends-bringing-warmth-personality-into-modern-homes-this-season/

#WinterDecor #HomeDecor #InteriorDesign #WinterHome #CozyHome #WarmNeutrals #LayeredTextures #HomeTrends #ModernHome #CozyVibes #InteriorTrends #HomeStyling #WinterStyle #DecorIdeas #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • Quiet Luxury Beauty: Why Sofwave™ Skin Tightening Fits the Understated Look

https://ritzherald.com/quiet-luxury-beauty-why-sofwave-skin-tightening-fits-the-understated-look/

#Sofwave #SkinTightening #QuietLuxury #Beauty #NonInvasive #Ultrasound #Collagen #FacialRejuvenation #AntiAging #Skincare #BeautyTreatment #MinimalDowntime #AestheticMedicine #NaturalResults #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • FAA Lifts Nationwide Ground Stop After Communications Failure

https://ritzherald.com/faa-lifts-nationwide-ground-stop-after-communications-failure/

#FAA #GroundStop #AirTrafficControl #FlightDelays #TravelDisruption #Aviation #ATC #FlightCancellations #AirportDelays #FAAOutage #AirTravel #TravelAlert #AviationNews #NationwideGroundStop #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • Euclid Telescope Releases Data on More Than 900 Million Galaxies

https://ritzherald.com/euclid-telescope-releases-data-on-more-than-900-million-galaxies/

#Euclid #ESA #SpaceTelescope #Galaxies #Astronomy #DarkEnergy #DarkMatter #SpaceScience #Cosmology #EuclidTelescope #Universe #Astrophysics #SpaceData #GalaxySurvey #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration
  • Britney Spears Reveals Long-Awaited Jewelry Line BTiny

https://ritzherald.com/britney-spears-reveals-long-awaited-jewelry-line-btiny/

#BritneySpears #BTiny #BTinyJewels #JewelryLine #CelebrityJewelry #PopStar #Fashion #Y2K #BritneySpearsJewelry #CelebrityBrand #Accessories #Jewelry #PopCulture #CelebrityFashion #GuestPost #GuestPosting #ContributeToBlog #WriteForUs #BloggersWanted #ContentCollaboration

© 2026 Fairmont Post. Published by The Ritz Herald. Editions: Markets Herald • Lincoln Citizen • Madison New York • Belmont Star • The Hudson Weekly

Address: 1177 6th Avenue, 5th Floor, New York, NY 10036. Removals: pr@ritzherald.com. Phone: (718) 313-5252. Mon-Fri: 9AM-5PM. Privacy Policy

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Business • Financial
  • Culture • Entertainment
  • Lifestyle • Travel
  • Technology • Science
  • Environment • Conservation
  • FinTech • Blockchain

© 2025 Fairmont Post